{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T08:06:20Z","timestamp":1779696380606,"version":"3.53.1"},"reference-count":33,"publisher":"SAGE Publications","issue":"20","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Stem Cells and Development"],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:p>Amniotic fluid contains multipotent cells and could be a source of stem cells for clinical use. Amniotic fluid cells (AFCs) are made up of a heterogeneous population of fetal cells that can be retrieved during pregnancy without ethical concerns as it is a standard clinical procedure. Studies of proliferation, multipotent marker expression, differentiation, and gene expression were performed after culturing with dexamethasone, valproic acid, and magnesium sulfate. There were correlations between known drug effects on the human fetus and changes seen in human AFCs in culture, as well as previously undescribed observations in neural and chondrogenic inducibility. Gene expression profiles confirmed these observations. AFC culture may provide a novel method to evaluate pharmacological agents before clinical use in pregnancy.<\/jats:p>","DOI":"10.1089\/scd.2016.0141","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T23:25:16Z","timestamp":1469229916000},"page":"1570-1579","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of Pharmacological Agents on Human Amniotic Fluid-Derived Stem Cells in Culture"],"prefix":"10.1177","volume":"25","author":[{"given":"Margaret","family":"Dziadosz","sequence":"first","affiliation":[{"name":"New York University Langone Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chan","sequence":"additional","affiliation":[{"name":"New York University Langone Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Basch","sequence":"additional","affiliation":[{"name":"New York University Langone Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce K.","family":"Young","sequence":"additional","affiliation":[{"name":"New York University Langone Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,10,15]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.11.006"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2011.587800"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e3283424f6e"},{"key":"e_1_3_3_5_2","first-page":"1","article-title":"Heterogeneity of stem cells in human amniotic fluid","volume":"3","author":"Chen Z","year":"2014","unstructured":"Chen Z, , Chan MK, , Steichenko N, , Wang F, , Liu L, , Perle MA, , Basch RS, and Young BK. (2014). Heterogeneity of stem cells in human amniotic fluid. J Regen Med, 3:1.","journal-title":"J Regen Med"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2014.0453"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1274"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2014.0110"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1515\/jpm-2015-0152"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2012.0215"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2014.0516"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2014.0426"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02129.x"},{"key":"e_1_3_3_14_2","first-page":"CD003935","article-title":"Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes","volume":"6","author":"Crowther CA","year":"2011","unstructured":"Crowther CA, , McKinlay CJ, , Middleton P, and Harding JE. (2011). Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev, 6:CD003935.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31825af2f0"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.20.2669"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2003.12.057"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801187"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000279152.66491.78"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.01162.x"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1502"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.117"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2012.0267"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(72)80547-X"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(80)90036-8"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.v3i3.31"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3016.2010.01147.x"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(93)90101-N"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-8994(97)00203-8"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008480-199804000-00003"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2003-4-5-p3"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13128"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/fn.83.2.F154"},{"key":"e_1_3_3_34_2","first-page":"1102","article-title":"Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5)","volume":"167","author":"Asztalos EV","year":"2013","unstructured":"Asztalos EV, , Murphy KE, , Willan AR, , Matthews SG, , Ohlsson A, , Saigal S, , Armson BA, , Kelly EN, , Delisle MF, et al. (2013). Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr, 167:1102\u20131110.","journal-title":"JAMA Pediatr"}],"container-title":["Stem Cells and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/scd.2016.0141","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/scd.2016.0141","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/scd.2016.0141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:40:22Z","timestamp":1779694822000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/scd.2016.0141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":33,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1089\/scd.2016.0141"],"URL":"https:\/\/doi.org\/10.1089\/scd.2016.0141","relation":{},"ISSN":["1547-3287","1557-8534"],"issn-type":[{"value":"1547-3287","type":"print"},{"value":"1557-8534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}